Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 50712-69-1 Chemical Structure| 50712-69-1

Structure of 50712-69-1

Chemical Structure| 50712-69-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 50712-69-1 ]

CAS No. :50712-69-1
Formula : C8H5BrClN
M.W : 230.49
SMILES Code : N#CC1=CC(Cl)=CC=C1CBr
MDL No. :MFCD09909826
InChI Key :CYBMZAPDOKDQJF-UHFFFAOYSA-N
Pubchem ID :12668052

Safety of [ 50712-69-1 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H314
Precautionary Statements:P260-P264-P270-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P405-P501
Class:8
UN#:3261
Packing Group:

Computational Chemistry of [ 50712-69-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.12
Num. rotatable bonds 1
Num. H-bond acceptors 1.0
Num. H-bond donors 0.0
Molar Refractivity 49.0
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

23.79 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.17
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.83
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.95
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.82
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.44
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.84

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.39
Solubility 0.094 mg/ml ; 0.000408 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.99
Solubility 0.237 mg/ml ; 0.00103 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.36
Solubility 0.00997 mg/ml ; 0.0000433 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.7 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.05

Application In Synthesis of [ 50712-69-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 50712-69-1 ]

[ 50712-69-1 ] Synthesis Path-Downstream   1~32

  • 1
  • [ 50712-69-1 ]
  • [ 143-33-9 ]
  • 5-chloro-2-(cyanomethyl)benzonitrile [ No CAS ]
  • [ 76519-93-2 ]
  • 2
  • [ 50712-69-1 ]
  • [ 143-33-9 ]
  • 5-amino-11-cyano-3,8-dichloro-11-(2-cyano-4-chlorobenzyl)-11H-indeno<1,2-c>isoquinoline [ No CAS ]
  • 2-cyano-1,2,3-tris(2-cyano-4-chlorophenyl)propane [ No CAS ]
  • 3
  • [ 50712-70-4 ]
  • [ 50712-69-1 ]
YieldReaction ConditionsOperation in experiment
77.1% With N-Bromosuccinimide; dibenzoyl peroxide; In tetrachloromethane; for 4h;Reflux; 2-(bromomethyl)-5-chlorobenzonitrile; 5-chloro-2-methylbenzonitrile (3.02 g, 20 mmol) was dissolved in 70 mL carbon tetrachloride. NBS (N-bromosuccinimide) (3.916 g, 22 mmol) and BPO (benzoyl peroxide) (0.194 g) were added, and refluxed for 4 h. The hot solution was subjected to filtration. The filtrate was spinned to dryness, and then dissolved in 20 mL chloroform, washed with saturated sodium carbonate solution and water, dried with Na2SO4, spinned to dryness, and subjected to column chromatography eluted with petroleum ether to afford 3.532 g white solid with a yield of 77.1%.
77.1% With N-Bromosuccinimide; dibenzoyl peroxide; In tetrachloromethane; for 4h;Reflux; Example 10 The preparation of (R)-2-[[7-(3-aminopiperidin-1-yl)-3-methyl-2-oxo-2,3-dihydroimidazo[4,5-b]pyridin-1-yl]methyl]-5-chlorobenzonitrile (Compound 10) trifluoroacetate 5-chloro-2-methylbenzonitrile (3.02 g, 20 mmol) was dissolved in 70 mL carbon tetrachloride. NBS (N-bromosuccinimide) (3.916 g, 22 mmol) and BPO (benzoyl peroxide) (0.194 g) were added, and refluxed for 4 h. The hot solution was subjected to filtration. The filtrate was spinned to dryness, and then dissolved in 20 mL chloroform, washed with saturated sodium carbonate solution and water, dried with Na2SO4, spinned to dryness, and subjected to column chromatography eluted with petroleum ether to afford 3.532 g white solid with a yield of 77.1 %.
54% With N-Bromosuccinimide; dibenzoyl peroxide; In tetrachloromethane; for 4h;Reflux; 5-chloro-2-methylbenzonitrile (2.5 g, 16.5 mmol) was dissolved in carbon tetrachloride (40 mL), and N-bromosuccinimide (2.94 g, 16.5 mmol) was added, followed by benzoyl peroxide (0.107 g, 0.33 mmol). The mixture was refluxed for 4 h, and the white succinimide residue was filtered off. The solvent was evaporated under reduced pressure and the residue was chromatographed on silica gel eluting with Hexanes:EtOAc (1:0 to 9:1). One pure fraction was collected (2.05 g, 54 % yield) as a white crystalline solid. [0137] 1H NMR (400 MHz, CDCl3) delta 7.65 (1H, d), 7.57 (1H, dd), 7.50 (1H, d), 4.60 (2H, s).
54% With N-Bromosuccinimide; dibenzoyl peroxide; In tetrachloromethane; for 4h;Reflux; a) 2-(Bromomethyl)-5-chlorobenzonitrile5-chloro-2-methylbenzonitrile (2.5 g, 16.5 mmol) was dissolved in carbon tetrachloride (40 ml_), and N-bromosuccinimide (2.94 g, 16.5 mmol) was added, followed by benzoyl peroxide (0.107 g, 0.33 mmol). The mixture was refluxed for 4 h, and the white succinimide residue was filtered off. The solvent was evaporated under reduced pressure and the residue was chromatographed on silica gel eluting with Hexanes:EtAcO (1 :0 to 9:1 ). One pure fraction was collected (2.05 g, 54 % yield) as a white crystalline solid.1 H NMR (400 MHz, CDCI3) ? 7.65 (1 H, d), 7.57 (1 H, dd), 7.50 (1 H, d), 4.60(2H, s).
Product distribution / selectivity; Preparative Example 67. Preparation of Table 1 Compound No. 236; Bromide 88, prepared from 5-chloro-2-methylbenzonitrile (Matrix Scientific) was combined with amine salt 6 according to the method of Preparative Example 13 to give 89. Nitrile 89 (377 mg, 0.75 mmol) was then dissolved in absolute ethanol (3 ml_). Hydroxylamine hydrochloride (150 mg, 1.5 mmol) and diisopropylethylamine (261 mul_, 194 mg, 1.5 mmol) were added. The reaction mixture was stirred at reflux for 16 hours. The reaction mixture was cooled to room temperature, neutralized with saturated sodium bicarbonate solution, and extracted with ethyl acetate. The organic solution was washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to give 90 as a yellow solid. Purification by silica gel chromatography (8% (7 M ammonia in methanol) in dichloromethane) gave 90 (167 mg, 42% yield). MS: [M + H]+ = 536. EPO <DP n="146"/>The nitro compound 90 was converted to 91 following procedures given in Preparative Examples 5 and 19, substituting methylamine for cyclopropylamine in the final step. MS: [M + H]+ = 651.
With N-Bromosuccinimide; dibenzoyl peroxide; In tetrachloromethane;Heating / reflux; Reference example 71; (1); To 5-chloro-2-methylbenzonitrile (7.8g) in carbon tetrachloride (50ml) were added N-bromosuccinimide (9.26g) and benzoylperoxide (515mg), and the mixture was stirred under reflux overnight. The reaction mixture was cooled and purified with silica gel column chromatography (hexane:ethyl acetate=30:1) to give compound (2) (8.87g) as a yellow transparent oil. 1HNMR(400MHz/CDCl3)delta(ppm):4.60(s,2H),7.50(d,1H,J=8.5Hz),7.57(dd,1H,J=2.3, 8.5Hz),7.65(d,1H,J=2.3Hz)

  • 4
  • [ 50712-69-1 ]
  • 3,8-Dichloro-11H-indeno[1,2-c]isoquinolin-5-ylamine [ No CAS ]
  • 5
  • [ 50712-69-1 ]
  • N-(3,8-Dichloro-11-cyano-5H-indeno[1,2-c]isoquinolin-5-yl)-acetamide [ No CAS ]
  • 6
  • [ 50712-69-1 ]
  • 5-Amino-3,8-dichloro-11H-indeno[1,2-c]isoquinoline-11-carbonitrile; hydrochloride [ No CAS ]
  • 7
  • [ 50712-69-1 ]
  • 5-Amino-3,8-dichloro-11H-indeno[1,2-c]isoquinoline-11-carbonitrile [ No CAS ]
  • 8
  • [ 51779-32-9 ]
  • [ 50712-69-1 ]
  • [ 658683-27-3 ]
YieldReaction ConditionsOperation in experiment
84% With sodium hydride; In tetrahydrofuran; at 20℃; for 28h; To a suspension of sodium hydride (1.91 g, 47.72 mmol) in anhydrous tetrahydrofuran (30 [ML)] at room temperature under nitrogen, was added a solution [OF 2-] [BROMOMETHYL-5-CHLORO-BENZONITRILE11] (10 g, 43.39 mmol) in anhydrous tetrahydrofuran (35 [ML),] followed by the dropwise addition of [DI-TERT] butyl imino dicarboxylate (10.37 g, 47.72 [MMOL)] in anhydrous tetrahydrofuran (30 [ML).] The reaction mixture was stirred at room temperature for 28 hours under nitrogen. The reaction was quenched with water (50 ml) and the solvent removed under reduced pressure. The aqueous layer was extracted with diethyl ether (3 x 100 ml), the combined organics washed with brine (50 [ML),] dried with magnesium sulfate, filtered and the solvent removed by evaporation under reduced pressure. The residue was purified by flash chromatography on silica gel eluting with a solvent gradient of heptane: ethyl acetate (4: 1) to give the title compound (13.45 g, 84 [%)] as a pale yellow solid. [1H-NMR] (400 MHz, [CDCI3)] : [9] = 1.46 (s, 18H), 4.98 (s, 2H), 7.28 (d, 1H), 7.53 (d, 1H), 7.61 (d, [1H).] LRMS [(APCI)] : m/z [M + H] [+] [389.] Microanalysis : Found: C, 59.37 ; H, 6.47 ; N, 7.09. [C18H23N204CI] requires C, 58. 93; H, 6.32 ; N, 7.64%.
  • 10
  • C16H24ClN7O*ClH [ No CAS ]
  • [ 50712-69-1 ]
  • C24H28Cl2N8O [ No CAS ]
YieldReaction ConditionsOperation in experiment
35% With triethylamine; sodium iodide; In N,N-dimethyl-formamide; at 25℃; for 3h; A mixture of Ei (hydrochloride salt form, 100 mg, 0.25 mmol) and sodium iodide (4 mg, 0.025 mmol) in DMF (1 mL) was treated with triethylamine (0.1 ml, 0.75 mmol) and <strong>[50712-69-1]2-cyano-4-chlorobenzyl bromide</strong> (0.11 ml, 0.5 mmol) at 250C. The reaction mixture was stirred for 3 hours at the temperature and diluted in CH2CI2. The organic solution was washed with saturated aqueous NaHCO3 solution, brine solution, dried over sodium sulfate, and concentrated in vacuo. The residual material was purified by EPO <DP n="71"/>preparative TLC (10% MeOH in CH2CI2) to afford the desired product F2 (45 mg, 35%). MS: M+H = 517
  • 11
  • [ 50712-69-1 ]
  • [ 18621-18-6 ]
  • 5-chloro-2-[(3-hydroxyazetidin-1-yl)methyl]benzonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
In dichloromethane; Step 1. DEEA (3.57 mL, 20.50 mmol) was added to a stirred mixture of 3-hydroxyazetidine hydrochloride (1.00 g, 9.11 mmol) and <strong>[50712-69-1]2-bromomethyl-5-chlorobenzonitrile</strong> (2.10 g, 9.11 mmol) in CH2Cl2 (75 mL). After 16 h the reaction mixture was concentrated and the residue was partitioned between ether and 1N HCl. The aqueous layer was washed with ether, made neutral with NaHCO3, saturated with NaCl and extracted into CH2Cl2. The organic layer was dried (Na2SO4) and evaporated to give 5-chloro-2-[(3-hydroxyazetidin-1-yl)methyl]benzonitrile (1.67 g) as a gum: 1H NMR (CDCl3, 400 MHz) delta 3.03 (m, 2H), 3.68 (m, 2H), 4.49 (t, J=6.2 Hz, 1H), 7.46 (d, J=8.6 Hz, 1H), 7.53 (d,d, J=2.2, 6.2 Hz, 1H), 7.60 (d, J=2.0 Hz, 1H).
  • 12
  • [ 288315-03-7 ]
  • [ 50712-69-1 ]
  • 5-chloro-2-[(3,3-difluoroazetidin-1-yl)methyl]benzonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; In dichloromethane; Step 1 DIEA (0.196 mL, 1.12 mmol) was added to a stirred mixture of 3,3-difluoroazetidine hydrochloride (64.8 mg, 0.50 mmol) and <strong>[50712-69-1]2-bromomethyl-5-chlorobenzonitrile</strong> (121.0 mg, 0.52 mmol) in CH2Cl2 (7 mL). After 16 h the reaction was partitioned between EtOAc and water. The organic layer was washed with water and brine, dried (Na2SO4) and evaporated. The residue was partitioned between 1N HCl and ether. The aqueous layer was made neutral with NaHCO3 and was extracted with CH2Cl2. The organic layer was dried with Na2SO4 and then evaporated to give 5-chloro-2-[(3,3-difluoroazetidin-1-yl)methyl]benzonitrile (67.8 mg) as a glass: 1H NMR (CDCl3, 400 MHz) delta 3.68 (t, J=11.9 Hz. 4H), 3.93 (s, 2H), 7.54 (m, 2H), 7.63 (d, J=2.2 Hz, 1H).
  • 13
  • [ 907207-95-8 ]
  • [ 50712-69-1 ]
  • C26H34Cl2N10O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
Example 20. Preparation of Table 1 Compound No. 1 EPO <DP n="114"/>Compound No. 1 of Table 1 , was prepared by alkylation of Compound A14 with 2-cyano benzyl bromide as in Preparative Example 14. Further treatment of the intermediate ester with hydroxylamine hydrochloride ( 13 mg, 300 mole%) in sodium carbonate and reflux for 16 h afforded Compound No 1. (11 mg).
  • 14
  • [ 58483-97-9 ]
  • [ 50712-69-1 ]
  • [ 1021873-80-2 ]
YieldReaction ConditionsOperation in experiment
Example 187 5-chloro-1-(4-chloro-2-cyanobenzyl)-2-imino-1,2-dihydropyridine-3-carboxamide hydrochloride To a solution of 2-amino-5-chloronicotinamide (0.16 g) in N,N-dimethylformamide (3 ml) was added <strong>[50712-69-1]2-(bromomethyl)-5-chlorobenzonitrile</strong> (0.32 g), and the mixture was stirred at 100C for 14 hr. The reaction mixture was quenched with saturated aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. The extract was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel chromatography (ethyl acetate:hexane=3:2 - 4:1). 2N Hydrochloric acid-methanol solution (1 ml) was added to the obtained yellow oil at room temperature, and the obtained precipitate was recrystallized from methanol-ethyl acetate to give the title compound (3 mg). 1H-NMR (DMSO-d6) d ppm 5.75 (2H, s), 7.24 (1H, d, J=2.0 Hz), 7.68 (1H, dd, J=8.3, 2.0 Hz), 8.05 (1H, d, J=8.3 Hz), 8.23 (1H, s), 8.60-8.78 (3H, m), 9.38-9.81 (2H, m).
  • 15
  • [ 50712-69-1 ]
  • [ 1427423-14-0 ]
  • 16
  • [ 50712-69-1 ]
  • [ 1427423-15-1 ]
  • 17
  • [ 50712-69-1 ]
  • [ 1427423-16-2 ]
  • 18
  • [ 50712-69-1 ]
  • [ 1427423-18-4 ]
  • 19
  • [ 50712-69-1 ]
  • [ 122-52-1 ]
  • [ 1427423-13-9 ]
YieldReaction ConditionsOperation in experiment
86% In toluene; at 140℃; for 4h; A solution of <strong>[50712-69-1]2-(bromomethyl)-5-chlorobenzonitrile</strong> (1.95 g, 8.46 mmol) and P(OEt)3 (3.63 mL, 21.15 mmol) in toluene were heated to 140 ºC for 4 hours. Excess of P(OEt)3 was removed in vacuo, and the product was extracted with ethyl acetate. Combined organic extracts were dried over MgSO4. Column chromatography on silica gel gave the desired product as a slightly yellow oil (2.1 g, 86% yield). [0139] 1H NMR (400 MHz, CDCl3) delta 7.65-7.58 (1H, m), 7.51 (2H, m), 4.19-4.00 (4H, m), 3.37 (2H, d), 1.29 (6H, t).
86% In toluene; at 140℃; for 4h; b) Diethyl 4-chloro-2-cyanobenzylphosphonateA solution of <strong>[50712-69-1]2-(bromomethyl)-5-chlorobenzonitrile</strong> (1 .95 g, 8.46 mmol) and P(OEt)3 (3.63 ml_, 21 .15 mmol) in toluene were heated to 140 5C for 4 hours. Excess of P(OEt)3 was removed in vacuo, and the product was extracted with ethyl acetate. Combined organic extracts were dried over MgS04. Column chromatography on silica gel gave the desired product as a slightly yellow oil (2.1 g, 86% yield).1 H NMR (400 MHz, CDCI3) ? 7.65 - 7.58 (1 H, m), 7.51 (2H, m), 4.19 - 4.00 (4H, m), 3.37 (2H, d), 1 .29 (6H, t).
  • 20
  • [ 50712-69-1 ]
  • 5-chloro-2-(4-chloro-2-fluorophenethyl)benzonitrile [ No CAS ]
  • 21
  • [ 50712-69-1 ]
  • 5-chloro-2-(4-chloro-2-fluorophenethyl)benzaldehyde [ No CAS ]
  • 22
  • [ 50712-69-1 ]
  • [ 1314945-32-8 ]
  • [ 1314945-59-9 ]
  • 23
  • [ 50712-69-1 ]
  • 2-(morpholinomethyl)-5-(2-(4-morpholinophenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)benzonitrile trifluoroacetate [ No CAS ]
  • 24
  • [ 50712-69-1 ]
  • C35H33N5O4S [ No CAS ]
  • 25
  • [ 50712-69-1 ]
  • 5-(6-(4-morpholinophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-((2-oxopyrrolidin-1-yl)methyl)benzonitrile [ No CAS ]
  • 26
  • [ 50712-69-1 ]
  • 2-((2-oxopyrrolidin-1-yl)methyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile [ No CAS ]
  • 27
  • [ 110-91-8 ]
  • [ 50712-69-1 ]
  • 5-chloro-2-(morpholinomethyl)benzonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In methanol; 2,2,2-trifluoroethanol; at 20℃; for 6h; Solid <strong>[50712-69-1]2-(bromomethyl)-5-chlorobenzonitrile</strong> (500 mgs, 2.17 mmol) was added in two portions to a stirred solution of morpholine (0.2 mL, 2.3 mmol) and triethylamine (0.3 mL, 2.17 mmol) in methanol (1 mL). After 6 hr at rt, the solvent was removed and the residue was dissolved in ethylacetate and washed with 1 N NaOH, water, saturated aqueous sodium chloride solution and dried (MgSO4). Filtration and concentration gave 5-chloro-2-(morpholinomethyl)benzonitrile which was used without purification for next step. LCMS-ESI+ (m/z): [M+H]+ calcd for C12H13N20 as (M+H)+ 237.7 found: 237.2. 1H NM (400 MHz, Chloroform-c ) delta 8.61 (d, J = 8.7 Hz, 1 H), 7.80 - 7.67 (m, 2H), 4.37 (s, 2H), 4.33 - 4.23 (m, 2H), 3.99 (m, 2H), 3.33 (m, 2H), 3.12 - 2.99 (m, 2H).
  • 28
  • [ 616-45-5 ]
  • [ 50712-69-1 ]
  • 5-chloro-2-((2-oxopyrrolidin-1-yl)methyl)benzonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
Sodium hydride (176 mgs, 4.41 mmol) was added to pyrrolidin-2-one (0.31 mL, 4.0 mmol) in DMF (10 mL) at 0C under nitrogen. The resulting solution was stirred at rt for 30 minutes and cooled again to 0C. 5-bromo-2-(chloromethyl)benzonitrile (921 mgs, 4.00 mmol) was added and the reaction stirred at 20 C for 2 hours. The residue was poured onto ice/water and extracted into ethyl acetate and the combined organics washed with saturated brine (100 mL), dried over Na2SO4, filtered and evaporated to give crude product. The crude product was purified by flash silica chromatography (30% EtOAc in hexanes). Pure fractions were evaporated to dryness to give 5-chloro-2-((2- oxopyrrolidin-1 -yl)methyl)benzonitrile. LCMS-ESI+ (m/z): [M+H]+ calcd for C12H11CIN2O as (M+H)+ 235.7 found: 235.2
  • 29
  • [ 50712-69-1 ]
  • 5-chloro-2-[(3-hydroxyazetidin-1-yl)methyl]benzylamine [ No CAS ]
  • 30
  • [ 50712-69-1 ]
  • 5-chloro-2-[(3,3-difluoroazetidin-1-yl)methyl]benzylamine [ No CAS ]
  • 31
  • [ 50712-69-1 ]
  • N-{5-chloro-2-[(3,3-difluoroazetidin-1-yl)methyl]benzyl}-L-prolinamide [ No CAS ]
  • 32
  • [ 50712-69-1 ]
  • N-{5-chloro-2-[(3,3-difluoroazetidin-1-yl)methyl]benzyl}-1-(tert-butoxycarbonyl)-L-prolinamide [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 50712-69-1 ]

Aryls

Chemical Structure| 77533-18-7

A178842 [77533-18-7]

2-(Bromomethyl)-3-chlorobenzonitrile

Similarity: 0.85

Chemical Structure| 57381-37-0

A170262 [57381-37-0]

2-Bromo-5-chlorobenzonitrile

Similarity: 0.77

Chemical Structure| 52864-54-7

A241256 [52864-54-7]

2-(2-Bromo-4-chlorophenyl)acetonitrile

Similarity: 0.75

Chemical Structure| 623-03-0

A149914 [623-03-0]

4-Chlorobenzonitrile

Similarity: 0.75

Chemical Structure| 622-95-7

A698850 [622-95-7]

1-(Bromomethyl)-4-chlorobenzene

Similarity: 0.75

Bromides

Chemical Structure| 77533-18-7

A178842 [77533-18-7]

2-(Bromomethyl)-3-chlorobenzonitrile

Similarity: 0.85

Chemical Structure| 57381-37-0

A170262 [57381-37-0]

2-Bromo-5-chlorobenzonitrile

Similarity: 0.77

Chemical Structure| 52864-54-7

A241256 [52864-54-7]

2-(2-Bromo-4-chlorophenyl)acetonitrile

Similarity: 0.75

Chemical Structure| 622-95-7

A698850 [622-95-7]

1-(Bromomethyl)-4-chlorobenzene

Similarity: 0.75

Chemical Structure| 766-80-3

A485240 [766-80-3]

1-(Bromomethyl)-3-chlorobenzene

Similarity: 0.73

Chlorides

Chemical Structure| 77533-18-7

A178842 [77533-18-7]

2-(Bromomethyl)-3-chlorobenzonitrile

Similarity: 0.85

Chemical Structure| 57381-37-0

A170262 [57381-37-0]

2-Bromo-5-chlorobenzonitrile

Similarity: 0.77

Chemical Structure| 52864-54-7

A241256 [52864-54-7]

2-(2-Bromo-4-chlorophenyl)acetonitrile

Similarity: 0.75

Chemical Structure| 623-03-0

A149914 [623-03-0]

4-Chlorobenzonitrile

Similarity: 0.75

Chemical Structure| 622-95-7

A698850 [622-95-7]

1-(Bromomethyl)-4-chlorobenzene

Similarity: 0.75

Benzyl Bromides

Chemical Structure| 77533-18-7

A178842 [77533-18-7]

2-(Bromomethyl)-3-chlorobenzonitrile

Similarity: 0.85

Chemical Structure| 622-95-7

A698850 [622-95-7]

1-(Bromomethyl)-4-chlorobenzene

Similarity: 0.75

Chemical Structure| 766-80-3

A485240 [766-80-3]

1-(Bromomethyl)-3-chlorobenzene

Similarity: 0.73

Chemical Structure| 7778-01-0

A107534 [7778-01-0]

1-(Bromomethyl)-3,5-dichlorobenzene

Similarity: 0.72

Chemical Structure| 18880-04-1

A437018 [18880-04-1]

3,4-Dichlorobenzyl bromide

Similarity: 0.70

Nitriles

Chemical Structure| 77533-18-7

A178842 [77533-18-7]

2-(Bromomethyl)-3-chlorobenzonitrile

Similarity: 0.85

Chemical Structure| 57381-37-0

A170262 [57381-37-0]

2-Bromo-5-chlorobenzonitrile

Similarity: 0.77

Chemical Structure| 52864-54-7

A241256 [52864-54-7]

2-(2-Bromo-4-chlorophenyl)acetonitrile

Similarity: 0.75

Chemical Structure| 623-03-0

A149914 [623-03-0]

4-Chlorobenzonitrile

Similarity: 0.75

Chemical Structure| 50712-68-0

A387592 [50712-68-0]

4-Chloro-2-methylbenzonitrile

Similarity: 0.73